Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alternative Treatment”

772 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 772 results

Not applicableStudy completedNCT06983600
What this trial is testing

The Effect of SuJok Application on Dysmenorrhea and Quality of Life in Young People With Primary Dysmenorrhea:

Who this might be right for
Dysmenorrhea (Disorder)Alternative Treatment
Muş Alparslan University 100
Testing effectiveness (Phase 2)UnknownNCT02481310
What this trial is testing

Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma

Who this might be right for
Adult Burkitt LymphomaB-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt LymphomaDiffuse Large B-Cell Lymphoma+2 more
Northwestern University 38
Post-approval studies (Phase 4)Ended earlyNCT01841931
What this trial is testing

Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients

Who this might be right for
Opioid Use DisorderOpioid DependenceChronic Pain
Theresa Jacob, PhD, MPH 4
Post-approval studies (Phase 4)UnknownNCT02973646
What this trial is testing

Peginterferon Alfa-2b Treatment in HBeAg(+) Chronic Hepatitis b Patients Based on Interferon Gene Mutation and Receptor Detection

Who this might be right for
Chronic Hepatitis b
Third Affiliated Hospital, Sun Yat-Sen University 100
Not applicableStudy completedNCT00897754
What this trial is testing

Gene Expression in Patients With Advanced or Metastatic Colorectal Cancer Receiving Bevacizumab

Who this might be right for
Colorectal Cancer
ECOG-ACRIN Cancer Research Group 200
Testing effectiveness (Phase 2)Study completedNCT00835900
What this trial is testing

An Alternative Dosing Schedule of Varenicline for Smoking Cessation

Who this might be right for
Smoking Cessation
Roswell Park Cancer Institute 60
Not applicableActive Not RecruitingNCT05370469
What this trial is testing

Real-Time Monitoring of Symptoms in Lung Cancer Patients Receiving Oral Targeted Therapies

Who this might be right for
Lung CancerEGFR Gene MutationEGFR+6 more
University of Virginia 30
Testing effectiveness (Phase 2)UnknownNCT02943486
What this trial is testing

Mesenchymal Stromal Cell Derivatives in the Treatment of Chronic Diabetic Foot Ulcers Type 1 and 2

Who this might be right for
Foot Ulcer, Diabetic
Universidad Autónoma de Bucaramanga 51
Post-approval studies (Phase 4)Not Yet RecruitingNCT07523867
What this trial is testing

Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study

Who this might be right for
Heart FailureDiabetic Kidney DiseaseHyperkalemia
Hospital de Messejana Dr. Carlos Alberto Studart Gomes 60
Large-scale testing (Phase 3)Ended earlyNCT03948464
What this trial is testing

Slow-Release Oral Morphine for the Treatment of Opioid Use Disorder

Who this might be right for
Opioid-Related DisordersOpiate Substitution TreatmentMorphine+2 more
M. Eugenia Socias 27
Testing effectiveness (Phase 2)Study completedNCT03583164
What this trial is testing

Evaluate F901318 (Olorofim) Treatment of Invasive Fungal Infections in Participants Lacking Treatment Options

Who this might be right for
Invasive Fungal Infections
F2G Biotech GmbH 203
Not applicableEnrolling By InvitationNCT07777900
What this trial is testing

Glycated Albumin Monitoring

Who this might be right for
Diabetes
Washington University School of Medicine 100
Not applicableEnded earlyNCT04698681
What this trial is testing

NGS Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes for the KEAPSAKE (CX-839-014) Trial

Who this might be right for
Non-Small Cell Lung CancerNon-squamous Non-small-cell Lung CancerNon-Squamous Non-Small Cell Neoplasm of Lung+3 more
Calithera Biosciences, Inc 20
Not applicableStudy completedNCT02220192
What this trial is testing

An Alternative Treatment for Cervical Intraepithelial Neoplasia Using the Focal Loop Electrosurgical Excision Procedure

Who this might be right for
High-grade Cervical Intraepithelial Neoplasia
University of Alabama at Birmingham 11
Not applicableNot Yet RecruitingNCT07755644
What this trial is testing

Minimally Invasive Non-Surgical Periodontal Treatment

Who this might be right for
PeriodontitisPeriodontitis (Stage 3)
Ataturk University 23
Large-scale testing (Phase 3)Not Yet RecruitingNCT06323148
What this trial is testing

Adjuvant Target Therapy Guided by ctDNA-MRD in Patients With EGFR-mutant II-IIIA Non-small Cell Lung Cancer (ECTOP-1022)

Who this might be right for
Lung CancerEGFR Gene MutationMinimal Residual Disease
Fudan University 226
Not applicableLooking for participantsNCT07722117
What this trial is testing

Evaluation of the Effect of Reiki on Pain After Lumbar Surgery

Who this might be right for
The Lumbar Spine Surgical InterventionArthrodesisSevere Herniated Disc+3 more
Clinique Bizet 60
Testing effectiveness (Phase 2)Study completedNCT00000233
What this trial is testing

Alternate Day Buprenorphine Administration, Phase X - 15

Who this might be right for
Opioid-Related Disorders
National Institute on Drug Abuse (NIDA)
Not applicableLooking for participantsNCT04740697
What this trial is testing

Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Institut Claudius Regaud 200
Testing effectiveness (Phase 2)Study completedNCT00464880
What this trial is testing

Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy

Who this might be right for
Diabetes Type 2
Novartis 24
Next Page